WCG Statistics Collaborative Revenue and Competitors

USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • WCG Statistics Collaborative's estimated annual revenue is currently $3.1M per year.(i)
  • WCG Statistics Collaborative's estimated revenue per employee is $81,600

Employee Data

  • WCG Statistics Collaborative has 38 Employees.(i)
  • WCG Statistics Collaborative grew their employee count by -17% last year.

WCG Statistics Collaborative's People

NameTitleEmail/Phone
1
Executive Director, BiostatisticsReveal Email/Phone
2
Contracts and Proposal ManagerReveal Email/Phone
3
Senior AdministratorReveal Email/Phone
4
Biostatistician IIReveal Email/Phone
5
Statistical ScientistReveal Email/Phone
6
Senior BiostatisticianReveal Email/Phone
7
Statistical Team LeaderReveal Email/Phone
8
Senior BiostatisticianReveal Email/Phone
9
Biostatistician IReveal Email/Phone
10
BiostatisticianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13M12743%N/AN/A
#2
$11.2M11062%N/AN/A
#3
$27.3M24310%N/AN/A
#4
$26M23725%$11MN/A
#5
$3.3M41-11%N/AN/A
#6
$11.6M11424%N/AN/A
#7
$1.6M225%N/AN/A
#8
$5.9M6410%N/AN/A
#9
$27.8M24828%N/AN/A
#10
$3.7M45-56%N/AN/A
Add Company

What Is WCG Statistics Collaborative?

Statistics Collaborative, Inc. was founded in 1990 by Janet Wittes, PhD. With nearly three decades of experience, we specialize in providing biostatistical consulting services for clients developing drugs, biologics, and medical devices. We work closely with our clients to develop research programs with scientific rigor and statistical validity, and are committed to maintaining the highest scientific and ethical standards. On December 31, 2019, Statistics Collaborative, Inc. became an Affiliate of WIRB-Copernicus Group, Inc. (WCG Clinical), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials. We have a wide range of statistical expertise including trial design, reporting for Data Monitoring Committees, creating randomization schemes, data analysis, and consultation for FDA presentations. We work in a wide range of therapeutic areas, with special emphasis on cardiovascular disease, infectious disease, orphan diseases, and vaccines. SCI staff helps our clients develop research programs with scientific rigor and statistical validity. We are committed to maintaining the highest scientific and ethical standards while providing timely and cost-effective services.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$3.1M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M380%N/A
#2
$7.8M386%$200M
#3
$7.4M380%N/A
#4
$7.6M38-14%N/A
#5
$6.2M38-39%N/A